Northern Trust’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Northern Trust’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,123	Closed	-$20K	–	4789
2022 Q3	$20K	Hold	1,123	–	–	﹤0.01%	4551
2022 Q2	$57K	Sell	1,123 -4,628	-80%	-$344K	﹤0.01%	4373
2022 Q1	$811K	Sell	5,751 -264	-4%	-$38.6K	﹤0.01%	3532
2021 Q4	$1.03M	Buy	6,015 +34	+0.6%	+$12.7K	﹤0.01%	3531
2021 Q3	$2.98M	Sell	5,981 -187	-3%	-$86.7K	﹤0.01%	3056
2021 Q2	$3.09M	Buy	6,168 +5,008	+432%	+$2.69M	﹤0.01%	3131
2021 Q1	$588K	Buy	1,160 +135	+13%	+$69.6K	﹤0.01%	3761
2020 Q4	$489K	Buy	1,025 +84	+9%	+$27.6K	﹤0.01%	3734
2020 Q3	$270K	Buy	941 +99	+12%	+$24.5K	﹤0.01%	3748
2020 Q2	$161K	Buy	842 +177	+27%	+$29.4K	﹤0.01%	3811
2020 Q1	$83K	Buy	665 +125	+23%	+$22.6K	﹤0.01%	3860
2019 Q4	$94K	Hold	540	–	–	﹤0.01%	3947
2019 Q3	$81K	Sell	540 -2,942	-84%	-$392K	﹤0.01%	3960
2019 Q2	$405K	Sell	3,482 -191	-5%	-$30.3K	﹤0.01%	3614
2019 Q1	$620K	Buy	3,673 +447	+14%	+$76.6K	﹤0.01%	3486
2018 Q4	$382K	Sell	3,226 -237	-7%	-$36.4K	﹤0.01%	3619
2018 Q3	$528K	Buy	3,463 +627	+22%	+$262K	﹤0.01%	3622
2018 Q2	$1.87M	Buy	2,836 +2,369	+507%	+$1.77M	﹤0.01%	3236
2018 Q1	$476K	Hold	467	–	–	﹤0.01%	3587
2017 Q4	$570K	Buy	467 +176	+60%	+$82.8K	﹤0.01%	3531
2017 Q3	$53K	Hold	291	–	–	﹤0.01%	4053
2017 Q2	$45K	Sell	291 -1,337	-82%	-$270K	﹤0.01%	4092
2017 Q1	$390K	Buy	1,628 +37	+2%	+$9.95K	﹤0.01%	3602
2016 Q4	$429K	Sell	1,591 -2	-0.1%	-$476	﹤0.01%	3569
2016 Q3	$354K	Sell	1,593 -13	-0.8%	-$3.65K	﹤0.01%	3587
2016 Q2	$621K	Buy	1,606 +1,365	+566%	+$1.49M	﹤0.01%	3468
2016 Q1	$163K	Hold	241	–	–	﹤0.01%	3797
2015 Q4	$253K	Hold	241	–	–	﹤0.01%	3685
2015 Q3	$208K	Sell	241 -1,037	-81%	-$868K	﹤0.01%	3730
2015 Q2	$909K	Sell	1,278 -152	-11%	-$162K	﹤0.01%	3380
2015 Q1	$3.23M	Buy	1,430 +11	+0.8%	+$18.8K	﹤0.01%	2802
2014 Q4	$1.46M	Sell	1,419 -33	-2%	-$35.3K	﹤0.01%	3267
2014 Q3	$1.54M	Hold	1,452	–	–	﹤0.01%	3251
2014 Q2	$3.64M	Buy	1,452 +35	+2%	+$71.4K	﹤0.01%	2735
2014 Q1	$2.7M	Sell	1,417 -16	-1%	-$37.8K	﹤0.01%	2956
2013 Q4	$3.06M	Buy	1,433 +151	+12%	+$357K	﹤0.01%	2899
2013 Q3	$2.88M	Buy	1,282 +186	+17%	+$360K	﹤0.01%	2871
2013 Q2	$1.9M	Buy	+1,096	New	+$1.74M	﹤0.01%	3017

Other funds holding AMPE

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ARG

Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Northern Trust's AMPE Position: Q4 2022 in Review

Northern Trust sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 1,123 shares — an estimated $20K sold.

Northern Trust first reported a position in AMPE in Q2 2013 and held it in 38 quarters. The position peaked at $3.64M in Q2 2014. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

Northern Trust reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
Northern Trust sold 1,123 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $20K.
Northern Trust first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 38 quarters.
Northern Trust's Ampio Pharmaceuticals Inc. position peaked at $3.64M in Q2 2014.
32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.